Plus Therapeutics Presents at HC Wainwright 26th Annual Global Investment Conference Page 1

AUSTIN, Texas, Sept. 04, 2024 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiation therapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announced that Marc H. Hedrick, MD, President and Chief Executive Officer of Plus Therapeutics, will provide a Company overview at the HC Wainwright 26^and Annual Global Investment Conference. The conference will be held from September 9 to 11, 2024 at the Lotte New York Palace Hotel.

Presentation time: Monday, September 9, 2024, available on demand from 7:00 a.m. ET